97989-94-1

Upstream product

• 97989-93-0 [(2R,3R,4R,5S)-2-(2,5-Bis-benzyloxy-3,4-dimethyl-phenyl)-3,5,6-tris-methoxymethoxy-2-methyl-tetrahydro-pyran-4-yl]-dimethyl-amine 
• 97989-81-6 (-)-benzyl β-D-gentosaminide 
• 98004-36-5 ((2R,3R,4S,5S)-2-Hydroxy-3,5-bis-methoxymethoxy-tetrahydro-pyran-4-yl)-methyl-carbamic acid methyl ester 
• 120041-97-6 (-)-benzyl 3-deoxy-3-(N-methoxycarbonyl-N-methylamino)-β-D-xylopyranoside 
• 97989-83-8 (3R,4S,5S)-2-hydroxy-4-(N-methoxycarbonyl-N-methylamino)-3,5-bis(methoxymethyloxy)-2-methyltetrahydropyran 
• 97989-82-7 (3R,4S,5S)-(+)-3,5-bis(methoxymethyloxy)-4-(N-methoxycarbonyl-N-methylamino)-tetrahydro-2-pyranone 
• 97989-93-0 [(2S,3R,4R,5S)-2-(2,5-Bis-benzyloxy-3,4-dimethyl-phenyl)-3,5,6-tris-methoxymethoxy-2-methyl-tetrahydro-pyran-4-yl]-dimethyl-amine 
• 97989-93-0 (2R,3R,4R,5S,6R)-(+)-2-(2,5-dibenzyloxy-3,4-dimethylphenyl)-4-dimethylamino-3,5,6-tris(methoxymethyloxy)-2-methyltetrahydropyran 
• 7143-64-8 (-)-benzyl 2-O-methanesulfonyl-β-D-arabinopyranoside 
• 120042-02-6 1,4-Dibenzyloxy-5-bromo-2,3-dimethylbenzene 
• 97989-85-0 (2S,3S,4R)-(-)-1-(tert-butyldimethylsilyloxy)-3-(N-methoxycarbonyl-N-methylamino)-2,4-bis(methoxymethyloxy)-5-hexanone 
• 120041-98-7 (-)-benzyl 3-deoxy-2,4-bis-(O-methoxymethyl)-3-(N-methoxycarbonyl-N-methylamino)-β-D-xylopyranoside 
• 120042-03-7 (2R,3R,4R,5S,6RS)-2-(2,5-dibenzyloxy-3,4-dimethylphenyl)-6-hydroxy-4-(N-methoxycarbonyl-N-methylamino)-3,5-bis(methoxymethyloxy)-2-methyltetrahydropyran 
• 97989-87-2 (2R,3R,4S,5S)-(-)-2-(2,5-dibenzyloxy-3,4-dimethylphenyl)-6-(tert-butyldimethylsilyloxy)-4-(N-methoxycarbonyl-N-methylamino)-2,4-bis(methoxymethyloxy)-2-hexanol 

Relevant academic research and scientific papers

CHIRAL SYNTHESIS OF THE DEF-RING SYSTEM OF NOGALAMYCIN

The DEF-ring system of nogalamycin (1), a potent antitumor antibiotic of the anthracycline family, was stereoselectively synthesized in an optically active form starting from readily available D-arabinose.